Maya Sasson

About the Author Maya Sasson

Maya Sasson, originally from San Francisco, California, is a financial writer focusing on U.S. stocks as well as analyst activity. Before diving into the world of financial writing, she earned a B.S. in Mathematics from Tufts University, and began her career as a data analyst for a software company.

3 Beaten-Down Biotech Stocks With +50% Upside Potential

After a stock endures a beating from the public market, it can be tempting to abandon ship. As any seasoned investor knows, if …

3 “Strong Buy” Healthcare Stocks With Triple-Digit Upside

To buy or not to buy, that’s the question. For even the most seasoned Wall Street observers, determining the ideal time to pull …

3 Healthcare Stocks That Can Double This Year

Which names are capable of hitting the ball out of the park? The pros will say healthcare stocks.

Goldman Sachs: 3 Healthcare Stocks to Snap Up Now

Stuck for fresh investing inspiration? You’re not alone.

3 Healthcare Stocks That Offer a Compelling Buying Opportunity

When shares fall, investor focus locks in. The first instinct, for some, is to avoid the name entirely after the investing alarm bells …

3 Monster Growth Stocks That Are Ready for the Next Leg Higher

At the end of the day, investors want to see returns. To accomplish this goal, seasoned Wall Street observers often turn to one …

Analysts: These 3 “Strong Buy” Penny Stocks Could Gain Over 50%

Penny stocks are controversial, to say the least. When it comes to these under $1 per share investment opportunities, Wall Street observers usually …

3 Healthcare Stocks With Important Catalysts in Q1

Blink, and you might just miss it. We are referring to the colossal gains that can be achieved by a select group of …

3 Top Healthcare Stocks That Could Gain 35% — Or More

Returns, that’s the name of the investing game. At the end of the day, investors are after the names that can help them …

Is Novavax (NVAX) Stock on the Mend? Wall Street Pro Weighs In

After a massive slip up last year, the tide appears to be turning for small cap vaccine maker Novavax (NVAX). In Wednesday’s trading …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts